Enhanced cerebral uptake of receptor ligands by modulation of P-glycoprotein function in the blood-brain barrier

Autor: Philippus Elsinga, P Doze, NH Hendrikse, W Vaalburg, van Aren Waarde
Přispěvatelé: Clinical pharmacology and pharmacy, Guided Treatment in Optimal Selected Cancer Patients (GUTS)
Jazyk: angličtina
Rok vydání: 2000
Předmět:
Zdroj: SYNAPSE, 36(1), 66-74. Wiley-Liss Inc.
Doze, P, Van Waarde, A, Elsinga, P H, Hendrikse, N H & Vaalburg, W 2000, ' Enhanced cerebral uptake of receptor ligands by modulation of P-glycoprotein function in the blood-brain barrier ', SYNAPSE, vol. 36, no. 1, pp. 66-74 . https://doi.org/10.1002/(SICI)1098-2396(200004)36:1<66::AID-SYN7>3.0.CO;2-J
Synapse, 36(1), 66-74. WILEY-LISS
ISSN: 0887-4476
DOI: 10.1002/(SICI)1098-2396(200004)36:1<66::AID-SYN7>3.0.CO;2-J
Popis: Low cerebral uptake of some therapeutic drugs can be enhanced by modulation of P-glycoprotein (P-gp), an ATP-driven drug efflux pump at the blood-brain barrier (BBB). We investigated the possibility of increasing cerebral uptake of the β-adrenergic ligands S-1'-[18F]-fluorocarazolol (FCAR) and [11C]-carazolol (CAR) in P-gp knockout mice (mdr1a (-/-)) and by modulation of P-gp with cyclosporin A (CsA) in rats. Specific and nonspecific binding of FCAR in the rat brain were doubled by CsA, while target/nontarget ratios and clearance from plasma (area under curve (AUG)) were not affected. Cerebral uptake of CAR in rats was much lower than FCAR and nonspecific. CsA increased this uptake 5-6-fold, not only due to P-gp modulation in the BBB but also to a 2-fold higher plasma AUG. In the CNS of mdr1a (-/-) mice, uptake of FCAR and CAR was, respectively, 2-fold and 3-fold higher than in mdr1a (+/+) mice. These results indicate that the cerebral uptake of β- adrenoceptor ligands can be increased by administration of P-gp modulators such as CsA without affecting regional distribution in the brain. P-gp modulation could improve the count statistics in PET studies of the CNS. (C) 2000 Wiley-Liss, Inc.
Databáze: OpenAIRE